... Oct 16
With this collaboration GSK is uniquely positioned with access to antibodies that synergistically target all three known CD226 checkpoints - TIGIT, CD96 and PVRIG.... Jun 14
To ease pressure on testing labs, ICMR relaxes testing requirements... May 05
... Jan 11
CSR funded vans were delivered to Karnataka government for immediate use... Aug 06
The EC approval was based on findings from the Phase III HAWK and HARRIER clinical trials, in which Beovu met the primary endpoint, demonstrating gains ... Feb 22
-Advertisements-